1 Min Read
Feb 7 (Reuters) - Kalvista Pharmaceuticals Inc
* SV Life Sciences Fund IV, l.p. reports 26.6 percent passive stake in Kalvista Pharmaceuticals Inc as of November 21, 2016 -sec filing Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.